SNHG5 and breast cancer: In summary, our study provided evidence that knockdown of SNHG5 suppressed the growth of BC cells, and reduced glycometabolism-related proteins levels, meanwhile inhibited the glucose consumption and lactate secretion, suggesting SNHG5 activated BACH1 expression to promote BC cell growth and glycolysis by targeting miR-299.